Atlas Venture Advisors, Inc. Buys Bicycle Therapeutics PLC

Author's Avatar
[email protected]
May 07, 2020
Article's Main Image
Investment company Atlas Venture Advisors, Inc. (Current Portfolio) buys Bicycle Therapeutics PLC during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Atlas Venture Advisors, Inc.. As of 2020Q1, Atlas Venture Advisors, Inc. owns 7 stocks with a total value of $74 million. These are the details of the buys and sells.
  • New Purchases: BCYC,

For the details of Atlas Venture Advisors, Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/atlas+venture+advisors%2C+inc./current-portfolio/portfolio

These are the top 5 holdings of Atlas Venture Advisors, Inc.
  1. Translate Bio Inc (TBIO) - 3,922,008 shares, 52.94% of the total portfolio.
  2. Bicycle Therapeutics PLC (BCYC) - 1,362,696 shares, 25.18% of the total portfolio. New Position
  3. Roku Inc (ROKU) - 57,707 shares, 6.83% of the total portfolio.
  4. Datadog Inc (DDOG) - 113,232 shares, 5.52% of the total portfolio.
  5. Snap Inc (SNAP) - 245,559 shares, 3.95% of the total portfolio.
New Purchase: Bicycle Therapeutics PLC (BCYC)

Atlas Venture Advisors, Inc. initiated holding in Bicycle Therapeutics PLC. The purchase prices were between $9.43 and $18, with an estimated average price of $12.7. The stock is now traded at around $14.12. The impact to a portfolio due to this purchase was 25.18%. The holding were 1,362,696 shares as of .



Here is the complete portfolio of Atlas Venture Advisors, Inc.. Also check out:

1. Atlas Venture Advisors, Inc.'s Undervalued Stocks
2. Atlas Venture Advisors, Inc.'s Top Growth Companies, and
3. Atlas Venture Advisors, Inc.'s High Yield stocks
4. Stocks that Atlas Venture Advisors, Inc. keeps buying
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Please Login to leave a comment